Surgical infection prophylaxis prior to left ventricular assist device implantation: A survey of clinical practice
Autor: | Rachel Miller, Carmelo A. Milano, Muath Bishawi, Ahmad Mourad, Stacey A. Maskarinec, Sana Arif |
---|---|
Rok vydání: | 2020 |
Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Prosthesis-Related Infections medicine.medical_treatment Levofloxacin 030204 cardiovascular system & hematology Prosthesis Implantation Aztreonam 03 medical and health sciences 0302 clinical medicine Vancomycin Surveys and Questionnaires Internal medicine medicine Humans Surgical Wound Infection Fluconazole business.industry Antibiotic Prophylaxis Antimicrobial Anti-Bacterial Agents Cephalosporins Clinical Practice Transplantation Regimen Cross-Sectional Studies 030228 respiratory system Ventricular assist device Drug Therapy Combination Surgery Heart-Assist Devices Rifampin Cardiology and Cardiovascular Medicine business Surgical Infections medicine.drug |
Zdroj: | Journal of Cardiac Surgery. 35:2672-2678 |
ISSN: | 1540-8191 0886-0440 |
DOI: | 10.1111/jocs.14882 |
Popis: | Background Short duration, antimicrobial prophylaxis that includes antistaphylococcal activity is recommended at the time of left ventricular assist device (LVAD) implantation to reduce infection-related complications. There continues to be wide variability in surgical infection prophylaxis (SIP) regimens among implantation centers. The aim of this study is to characterize current SIP regimens at different LVAD centers. Methods A survey study was conducted from 26 September 2017 to 25 October 2017. Surveys were distributed electronically to LVAD coordinators and infectious diseases specialists at 75 US medical centers identified as having an LVAD program. Data collection included information about antimicrobial selection, duration, Staphylococcus aureus screening, and decolonization procedures. Results We received 29 survey responses. The majority of surveys were completed by infectious diseases physicians (72.4% [21 out of 29]). Most responding centers reported LVAD programs established for greater than 10 years (20 out of 29 [69%]). Cardiac transplantation was performed in 28 out of 29 (96%) centers. Of centers reporting a defined SIP regimen for non-penicillin allergic patients (96% [28 out of 29]), 17.9% (5 out of 28) reported a four-drug regimen, 35.7% (10 out of 28) reported a three-drug regimen, and 46.4% (13 out of 28) reported a two-drug regimen, while no centers reported a single-drug regimen. Empiric fluconazole was common (50% [14 out of 28]) and 96.4% (27 out of 28) of regimens included vancomycin. Duration of antimicrobial prophylaxis (24 hours to 5 days), S. aureus screening, decolonization procedures, and alterations due to drug allergies varied across participating centers. Conclusions Our survey results indicate wide variation in SIP regimens among participating LVAD centers. These results highlight the need for studies evaluating the implications of SIP regimens, and whether clinical factors that prolong antimicrobial duration impact postoperative infection rates. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |